MyBlueDotsHedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing MyBlueDots4 weeks ago01 mins COPENHAGEN, Denmark & PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko and Hedia launched their interoperable solution, combining connected care, remote patient monitoring, and digital therapeutics for diabetes. Post navigation Previous: Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025Next: BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds MyBlueDots7 hours ago 0
Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics MyBlueDots7 hours ago 0